ChiCTR2600121439 版本V1.0 版本创建时间2026/03/31 08:52:06 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600121439 

最近更新日期:

Date of Last Refreshed on:

2026-03-31 08:51:40 

注册时间:

Date of Registration:

2026-03-31 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

腋下、外阴乳房外Paget病皮肤镜下表现异同

Public title:

Dermatoscopic Features of Paget’s Disease in the Armpit, External Genitalia, and Breast: Similarities and Differences

注册题目简写:

English Acronym:

研究课题的正式科学名称:

腋下、外阴乳房外Paget病皮肤镜下表现异同

Scientific title:

Dermatoscopic Features of Paget’s Disease in the Armpit, External Genitalia, and Breast: Similarities and Differences

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陈少宁 

研究负责人:

陈少宁 

Applicant:

Chen Shaoning 

Study leader:

Chen Shaoning 

申请注册联系人电话:

Applicant telephone:

+86 132 0925 0736

研究负责人电话:

Study leader's telephone:

+86 132 0925 0736

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

chshn_420@163.com

研究负责人电子邮件:

Study leader's E-mail:

chshn_420@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

陕西省汉中市汉台区石马路中段1111号

研究负责人通讯地址:

陕西省汉中市汉台区石马路中段1111号

Applicant address:

Department of Dermatology, Hanzhong Railway Central Hospital, No.1111, Middle Section of Shimalu Road, Hantai District, Hanzhong City, Shaanxi Province

Study leader's address:

Department of Dermatology, Hanzhong Railway Central Hospital, No.1111, Middle Section of Shimalu Road, Hantai District, Hanzhong City, Shaanxi Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

汉中市铁路中心医院

Applicant's institution:

Hanzhong Railway Central Hospital

研究负责人所在单位:

汉中市铁路中心医院

Affiliation of the Leader:

Hanzhong Railway Central Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025003

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

汉中市铁路中心医院学术与伦理委员会

Name of the ethic committee:

Hanzhong Railway Central Hospital Academic and Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2025-09-18 00:00:00

伦理委员会联系人:

常丽

Contact Name of the ethic committee:

Chang Li

伦理委员会联系地址:

陕西省汉中市汉台区石马路中段1111号汉中市铁路中心医院伦理委员会办公室

Contact Address of the ethic committee:

Office of the Ethics Committee, Hanzhong Railway Central Hospital, No.1111, Middle Section of Shimalu Road, Hantai District, Hanzhong City, Shaanxi Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 916 221 2930

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

汉中市铁路中心医院

Primary sponsor:

Hanzhong Railway Central Hospital

研究实施负责(组长)单位地址:

陕西省汉中市汉台区石马路中段1111号

Primary sponsor's address:

No.1111, Middle Section of Shimalu Road, Hantai District, Hanzhong City, Shaanxi Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

陕西

市(区县):

Country:

China

Province:

Shaanxi

City:

单位(医院):

汉中市铁路中心医院

具体地址:

陕西省汉中市汉台区石马路中段1111号

Institution
hospital:

Department of Dermatology, Hanzhong Railway Central Hospital

Address:

No.1111, Middle Section of Shimalu Road, Hantai District, Hanzhong City, Shaanxi Province

经费或物资来源:

自筹

Source(s) of funding:

Self-raising

Target disease:

Paget's disease of the breast

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

病例研究 

Study design:

Case study 

研究目的:

1.总结4例不同解剖部位EMPD(外阴/腋窝等)的皮肤镜共性特征,提炼核心诊断指标; 2.对比分析不同部位EMPD在背景颜色、血管形态、白色结构等方面的差异特征; 3评估皮肤镜特征对不同部位EMPD的诊断价值,优化临床无创诊断思路。  

Objectives of Study:

1. Summarize the common dermoscopic features of 4 cases of EMPD in different anatomical sites (vulva, axilla, et and distill core diagnostic indicators; 2. Compare and analyze the differential characteristics of EMPD in different sites regarding background color, vascular morphology, and white structures; 3. Evaluate the diagnosvalue of dermoscopic features for EMPD in different sites and optimize clinical non-invasive diagnostic strategies.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 2018年3月-2025年8月本院经组织病理+免疫组化确诊的原发性EMPD患者; 2. 有完整临床资料、标准化皮肤镜图像(非接触式、偏振光模式); 3. 病灶解剖部位明确(外阴/腋窝),临床资料可追溯。

Inclusion criteria

1. Patients with primary EMPD confirmed by histopathology and immunohistochemistry in our hospital from March 2018 to August 2025; 2. With complete clinical data, standardized dermoscopic images (non-contact, polarized light mode); 3. Anatomical location of the lesion is clear (external genitalia/axilla), and clinical data are traceable.

排除标准:

1.继发性EMPD、乳房Paget病、合并其他皮肤恶性肿瘤; 2.皮肤镜图像模糊、局部用药干扰图像观察; 3.临床/病理资料缺失,无法完成特征评估。

Exclusion criteria:

1. Secondary EMPD, Paget's disease of the breast, combined with other cutaneous malignancies; 2. Dermatoscopic images are blurred, and topicalns interfere with image observation; 3. Clinical/pathological data missing, unable to complete feature assessment.

研究实施时间:

Study execute time:

From 2025-09-18 00:00:00 To 2026-09-18 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-09-18 00:00:00 To 2026-09-18 00:00:00  

干预措施:

Interventions:

组别:

腋下、外阴乳房外Paget病

样本量:

4

Group:

Paget's disease in the axillary region, vulva, and external breasts

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

陕西 

市(区县):

 

Country:

China 

Province:

Shaanxi 

City:

 

单位(医院):

汉中市铁路中心医院 

单位级别:

二甲 

Institution
hospital:

Department of Dermatology, Hanzhong Railway Central Hospital

Level of the institution:

secondary-level

测量指标:

Outcomes:

指标中文名:

皮肤镜下特点:共性指标,乳红色背景、亮白色结构、点状/球状血管阳性率

指标类型:

主要指标

Outcome:

Dermatoscopic features: Common indicators,Milky red background, bright white structure, positive rate of punctate/globular vessels.

Type:

Primary indicator

测量时间点:

测量方法:

2名以上高年资医师观察

Measure time point of outcome:

Measure method:

Observation by more than two senior physicians

指标中文名:

皮肤镜下特点:差异指标,血管类型/分布、色素模式、鳞屑类型、糜烂发生率、边界清晰度

指标类型:

次要指标

Outcome:

Dermatoscopic features: differential indicators,Vessel type/distribution, pigmentation pattern, scale type, erosion rate, border clarity

Type:

Secondary indicator

测量时间点:

测量方法:

2名以上高年资医师观察

Measure time point of outcome:

Measure method:

Observation by more than two senior physicians

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 50 years
最大 Max age 91 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究公开发表后半年,邮件联系研究负责人合理获取。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Six months after the publication of the research, contact the research leader via email to obtain reasonable information.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2026-03-31 08:51:40